Helmholtz Munich

Deciphering the molecular mechanisms that control T cell-driven immune responses will create critical knowledge for future therapies against autoimmune diseases or immune cell therapies against cancer

Click & View

The Research Unit Molecular Immune Regulation (AMIR) investigates the differentiation of T helper cells with a focus on post-transcriptional gene regulation. T helper cell differentiation enables specific immune responses, however, hyper- or hypofunctional T helper cells critically contribute to inflammatory and autoimmune diseases or to the lack of immune responses during chronic infections and tumor formation, respectively. We analyze molecular interactions and search for diagnostic markers to develop new therapeutic approaches.

AMIR - about our research 1 - centrifuge

New Research Findings, Molecular Targets and Therapeutics, AMIR, July 25, 2022

Researchers gain a fundamental insight for epitranscriptomics and immune response. The research group around Vigo Heissmeyer and Taku Ito-Kureha of Helmholtz Munich and Ludwig-Maximilians-Universität München has revealed the essential function of m6A…

Prof. Vigo Heissmeyer

Head of Molecular Immune Regulation View profile

Dr. Kai Höfig

Senior Scientist

Dr. Stephanie Edelmann

Postdoc

Sabine Hartig

Technische Assistentin

0

Impact factor since 2021

0

Reviews since 2021

0

Nightshifts per PhD

0

Dedication required

Molecular Targets and Therapeutics Center Research Unit Molecular Immune Regulation (AMIR)

Click & View

About our Research

How Tiny Changes Help T Cells to Survive